January 1, 2026 came and went. CMS changed the accreditation cycle from three years to one — and a surprising number of active DMEPOS suppliers are still operating as if the old rules apply.
DMEPOS accreditation is a mandatory CMS certification that every Medicare DMEPOS billing supplier must hold. No accreditation means no Medicare enrollment. No enrollment means no billing. This guide covers the complete picture for licensed providers in 2026: what accreditation is, how it differs from your state DME license, which accrediting organization fits your practice, what the 2026 rule changes demand from your operations, what it realistically costs, and how accreditation works when you dropship rather than stock inventory.
If you are still untangling the DMEPOS accreditation vs. DME license question — which most providers entering the Medicare space are — this guide addresses that directly and gives you a side-by-side comparison you can act on.
What Is DMEPOS Accreditation — and Who Actually Needs It?
DMEPOS stands for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies. Accreditation is the process by which a CMS-approved independent organization verifies that your supplier operation meets federal quality standards under 42 CFR §424.57. Those standards cover your operations, patient safety procedures, documentation practices, complaint resolution process, and staff qualifications.
Any supplier billing Medicare Part B for DME, prosthetics, orthotics, medical supplies, home dialysis equipment, therapeutic shoes, or parenteral and enteral nutrition must be accredited. This requirement has been federal law since 2009 under the Medicare Improvement for Patients and Providers Act. The 2026 rule changes did not create the requirement — they made maintaining it considerably harder.
(Source: CMS.gov — 42 CFR §424.57)
Exemptions exist. They are narrower than most providers assume. Eligible professionals physicians, physical therapists, occupational therapists, nurse practitioners, and a defined list of others — are exempt only when supplying DMEPOS exclusively to their own patients as a direct extension of their professional service. The moment you begin supplying equipment outside that direct care relationship, or billing as a stand-alone supplier, the exemption is gone. Pharmacies may qualify if DMEPOS billing represents less than 5% of total pharmacy sales and they meet several additional CMS criteria.
(Source: MIPPA Section 154(b) — Exemptions)
Here is what almost every accreditation guide leaves out: accreditation covers the specific supplier location listed on your Medicare enrollment — not your practice broadly. Open a second location and start billing Medicare from it before that location is surveyed and accredited, and that location is out of compliance. Your original accredited location is irrelevant. Under the 2026 rules, new locations must be fully surveyed before accreditation is granted — CMS eliminated the previous 3-month operational grace period. There is no temporary status anymore.
DMEPOS Accreditation vs. DME License — Why Most Providers Get This Wrong
This confusion costs new providers three to six months of billing eligibility. Accreditation and a state DME license are two entirely separate requirements, issued by two entirely separate bodies, covering two different aspects of your authority to supply equipment.
Your state DME license is a business authorization. Your state licensing board issues it. It gives you legal authority to operate as a DME supplier within that state. Your DMEPOS accreditation is a federal quality certification. A CMS-approved accrediting organization issues it. CMS requires it before activating your Medicare billing privileges. One without the other gets you nowhere.
|
|
DMEPOS Accreditation
|
State DME License
|
|---|---|---|
|
Issued by
|
CMS-approved AO
|
State licensing board
|
|
Required for
|
Medicare billing eligibility
|
Legal authority to supply DME in-state
|
|
Scope
|
Quality standards + operations
|
Business authorization
|
|
Renewal cycle
|
Annual (as of Jan 1, 2026)
|
Varies by state (1–3 years)
|
|
Estimated cost
|
$1,500–$5,000+ first year
|
$200–$2,000+ depending on state
|
|
Timeline
|
3–6 months
|
30–120 days depending on state
|
|
Can run in parallel?
|
Yes
|
Yes
|
The standard advice — get your state license first, then start accreditation — is outdated. Both processes can and should run simultaneously. A provider who sequences them loses two to four months of billing eligibility for no compliance reason. Start your AO application as soon as your NPI is active and your business entity is established. Do not wait for your state license to land before opening the accreditation process.
The step-by-step guide to getting your DME license covers the state licensing process in full. If you are operating across multiple states, the state-by-state DME licensing requirements guide maps out exactly what each state requires and in what timeframe.
The 5 CMS-Approved Accreditation Organizations and How to Actually Choose One?
Every guide on DMEPOS accreditation lists the five CMS-approved AOs. Almost none of them explain how to choose between them. That is the only question that matters once you know they exist.
The five CMS-approved AOs are:
ACHC (Accreditation Commission for Health Care) — broad DME and home health focus; one of the most widely used AOs for general DMEPOS suppliers
ABC (American Board for Certification in Orthotics, Prosthetics & Pedorthics) — specialized in orthotics and prosthetics; purpose-built for providers billing L-coded braces and orthopedic devices
CHAP (Community Health Accreditation Partner) — oriented toward home health and home-based care models; strong fit for home health agencies adding a DME component
NABP (National Association of Boards of Pharmacy) — designed specifically for pharmacies distributing DMEPOS products
The Compliance Team — a smaller AO known for hands-on support during the process; frequently recommended for first-time applicants who want more guidance through policy alignment
Choosing the wrong AO for your product category creates friction that is entirely avoidable. A NABP surveyor reviewing an orthopedic brace practice is approaching your documentation through a pharmacy compliance lens, not an orthotics lens. A surveyor from ABC reviewing a knee brace and ambulatory aid supplier is going to understand your product line, your HCPCS codes, and your documentation requirements at a level that makes the survey faster and cleaner.
For providers billing L-coded orthopedic braces — knee, hip, wrist, ankle, back, cervical — ABC is the most category-aligned choice. For broader DME practices covering ambulatory aids, bathroom safety, TENS units, and braces together, ACHC offers the widest product coverage and the most established support resources for new applicants.
Before committing, request a fee schedule and average timeline estimate from at least two AOs. First-year application costs, annual fees, and multi-location pricing vary enough to be worth a direct comparison.
The 2026 Annual Survey Rule — What Changed and What It Actually Demands?
Starting January 1, 2026, CMS replaced the three-year DMEPOS accreditation cycle with annual surveys for most suppliers. Existing suppliers transition to annual renewal at the expiration of their current three-year cycle. New suppliers and any supplier adding a new location must be surveyed before accreditation is granted — no grace period, no temporary status.
(Source: CMS MLN905710 — DMEPOS Accreditation Fact Sheet, December 2025)
The mechanics of the change are straightforward. The operational implications are not.
Under the three-year model, a provider could treat accreditation as a periodic compliance event — assemble documentation, pass the survey, then operate on relative autopilot for the next 36 months. That approach does not survive annual surveys. Your policies, delivery records, staff training logs, complaint documentation, and quality improvement records must be current and audit-ready at all times. Not assembled in the 60 days before a scheduled review. Always. The providers who will struggle with this shift are not the ones who were cutting corners before. They are the ones who were compliant in a reactive way and now need to operate in a continuous one.
The second 2026 change is getting almost no coverage in provider-facing content, which is a problem given its business implications: effective January 1, 2026, CMS expanded the 36-month ownership rule to require that any DMEPOS supplier undergoing a change in majority ownership must enroll as a new supplier. That means restarting the accreditation process from the beginning. If your practice is considering an acquisition, a partnership restructuring, or a majority ownership transfer, that transaction now carries a full re-accreditation requirement. Budget for a three-to-six-month accreditation gap in any ownership change timeline.
(Source: CMS.gov — DMEPOS Enrollment Page)
Key 2026 Dates at a Glance
January 1, 2026 — Annual survey requirement takes effect for new suppliers and new locations; grace period eliminated
Upon current cycle expiration — Existing suppliers shift to annual renewal at their next accreditation expiration date
January 1, 2026 — Expanded 36-month majority ownership rule takes effect
How to Get DMEPOS Accreditation — The Steps That Actually Matter?
The accreditation process runs six steps. The timeline from application to active accreditation status is three to six months for most new suppliers. The spread almost always comes down to one variable: how prepared you are at step three.
- Choose your AO. Use the criteria above. Match the AO to your product category and practice type. Do not default to name recognition.
- Submit your application. Provide your NPI, business entity documentation, practice location details, and ownership information. Have these ready before you begin — incomplete applications are a common, avoidable source of delay.
- Policy and procedure alignment. This is where most first-time applicants stall — and where the three-month providers separate from the six-month providers. CMS quality standards under 42 CFR §424.57 require documented internal policies covering patient rights, equipment delivery and setup, complaint resolution, staff qualifications, and ongoing quality improvement. Budget two to six weeks for this step alone, and consider using your AO’s preparation resources before your survey date is set.
- On-site survey. Your AO conducts a survey of your supplier location — typically unannounced after the initial survey. The surveyor reviews documentation, interviews staff, inspects facilities, and assesses operational compliance against CMS quality standards.
- Receive accreditation status. Your AO notifies CMS directly upon granting accreditation. CMS updates your enrollment record. Your Medicare billing privileges are activated or maintained. You do not submit accreditation documentation to CMS yourself.
- Annual renewal. As of January 1, 2026, build this into your operational calendar every 12 months. Treat it as ongoing maintenance, not an annual event.
Three to six months, start to finish. The providers who land at three months arrive at step three prepared. The ones who land at six months — or beyond — underestimated the documentation requirement and are assembling policies from scratch mid-process.
What DMEPOS Accreditation Actually Costs in 2026?
The cost question comes with a widely misunderstood component that causes unnecessary sticker shock: the surety bond.
CMS requires a $50,000 surety bond per NPI for enrolled DMEPOS suppliers. Most providers read that as a $50,000 cash requirement. It is not. A surety bond is an insurance instrument — you pay an annual premium to a bonding company, which holds the bond on your behalf. The annual premium for a $50,000 DMEPOS surety bond typically runs $500 to $1,500 per year depending on your credit profile. The $50,000 face value never leaves your account.
(Source: CMS Final Rule — Surety Bond Requirement, Federal Register, January 2, 2009)
Realistic first-year cost breakdown for a single-location provider:
AO application fee: $500–$2,000 depending on AO and supplier size
Annual accreditation fee: $1,000–$3,500+ depending on AO and number of locations
Surety bond annual premium: $500–$1,500
Policy preparation support (optional): $500–$3,000 if using outside assistance
Total realistic first-year cost: $2,500–$8,000 for a single location. Multi-location practices should request explicit multi-site pricing from their chosen AO before budgeting — the per-location fee structure varies significantly across AOs.
Confirm current fee schedules directly with your chosen AO. These are published-range estimates, not guaranteed figures.
How DMEPOS Accreditation Works When You Dropship Equipment?
This is the question the rest of the internet is not answering, because every other guide assumes you are a self-stocking supplier with a physical warehouse.
If you are a licensed provider fulfilling equipment through a dropship supplier — shipping PDAC-approved product directly to your patient without holding inventory — the accreditation requirement is identical. Accreditation is tied to the Medicare billing entity, not the fulfillment model. The entity submitting the claim must be accredited. Full stop.
What changes in a dropship model is your audit exposure, and this is where providers consistently underestimate their risk.
Your accreditation covers your compliance posture. Your supplier’s documentation practices determine whether that compliance posture holds up when an auditor pulls your claim file. If your dropship supplier cannot produce a delivery confirmation, a PDAC approval certificate at the specific SKU level, or a compliant Certificate of Medical Necessity — the compliance gap belongs to you. Not the supplier. The accreditation is yours. The audit risk sits with the billing entity.
This is precisely why product-level PDAC approval matters more than category-level claims. A supplier who tells you their products are “PDAC approved” without providing SKU-specific approval documentation is giving you incomplete protection. PDAC approval is specific to the exact product, the exact manufacturer, and the exact HCPCS code it was evaluated under. A brace that appears identical to an approved product but originates from a different manufacturer is not approved for billing under that L-code — regardless of what the supplier’s marketing materials suggest.
For licensed providers building a compliant dropship DME program, our guide on how to become an authorized Medicare supplier covers the full Medicare enrollment picture alongside the accreditation requirement.
This is precisely why product-level PDAC approval matters more than category-level claims. A supplier who tells you their products are “PDAC approved” without providing SKU-specific approval documentation is giving you incomplete protection. PDAC approval is specific to the exact product, the exact manufacturer, and the exact HCPCS code it was evaluated under. A brace that appears identical to an approved product but originates from a different manufacturer is not approved for billing under that L-code — regardless of what the supplier’s marketing materials suggest.
For licensed providers building a compliant dropship DME program, our guide on how to become an authorized Medicare supplier covers the full Medicare enrollment picture alongside the accreditation requirement.
Who This Is Built For?
Ava’s dropship partnership program is built for you if:
1) You are a licensed DME provider — or actively in the process of obtaining your DME license and DMEPOS accreditation.
2) You want to bill Medicare for orthopedic braces, ambulatory aids, or related DMEPOS products without managing physical inventory.
3) You are already billing Medicare or setting up your billing workflow and need a PDAC-approved supplier who ships direct to your patients with full documentation on every order
This is not the right fit if:
1) You are looking to sell DME products direct-to-consumer through retail or ecommerce channels
2) You do not have — or are not actively pursuing — a DME license and DMEPOS accreditation
3) You are looking for wholesale pricing to stock your own inventory or distribution operation
Frequently Asked Questions About DMEPOS Accreditation
First-year costs for a single-location DMEPOS supplier typically run $2,500–$8,000, covering AO application fees ($500–$2,000), annual accreditation fees ($1,000–$3,500), and a surety bond annual premium ($500–$1,500). The $50,000 surety bond is not a cash outlay — it is an insurance instrument with an annual premium. Multi-location practices should request explicit multi-site pricing from their chosen AO.
A state DME license is a business authorization issued by your state licensing board — it gives you legal authority to supply DME within that state. DMEPOS accreditation is a federal quality certification issued by a CMS-approved AO — it is what CMS requires before activating your Medicare billing privileges. You need both. Both processes can run simultaneously, and they should.
As of January 1, 2026, CMS expanded the 36-month ownership provision: any DMEPOS supplier undergoing a change in majority ownership must enroll as a new supplier, which includes restarting the accreditation process from the beginning. Any practice considering acquisition, partnership restructuring, or majority ownership transfer should account for a full 3–6 month re-accreditation timeline in their planning.
(Source: CMS.gov — DMEPOS Enrollment Page)
Three to six months from application submission to active billing status for most new suppliers. The primary variable is step three — policy and procedure alignment under 42 CFR §424.57. Providers who arrive with documented policies already written to CMS standards consistently complete the process closer to three months. Those who underestimate the documentation requirement land closer to six.
Yes. Accreditation is tied to the billing entity — the licensed provider submitting the Medicare claim — not to the fulfillment method. Whether you stock inventory or use a third-party dropship supplier, your Medicare enrollment requires active accreditation. In a dropship model, your supplier's documentation practices directly affect your audit exposure, which makes supplier selection a compliance decision, not just a logistics one.
What Happens After You Contact Ava
No vague discovery calls. Here is exactly what the process looks like:
1) We verify your DME license and NPI — one business day
2) We onboard your practice to our ordering portal — two to three business days
3) You place your first order — we ship PDAC-approved product directly to your patient, HIPAA-compliant, with full delivery documentation included on every order
Most providers are placing their first order within one week of reaching out.
Common Questions Before Partnering
No minimum orders — one unit or one hundred, the process is identical.
No long-term contracts — your partner status carries no monthly volume commitment.
Full documentation on every shipment — delivery confirmation, SKU-level PDAC approval records, and CMN support are standard, not optional.
State-specific questions answered upfront — if you have licensing questions before your first order, our team addresses those before you commit to anything.
If you are a licensed DME provider ready to offer compliant, PDAC-approved equipment without the inventory overhead — Ava Medical Supply was built for exactly this.
We partner with licensed providers, clinics, physical therapists, chiropractors, and telehealth practices across all 50 states. PDAC-approved products, HIPAA-compliant direct-to-patient shipping, and full documentation on every order — handled.
Apply to Partner with Ava Medical Supply.
Or call us directly: +1 (561) 880-4394
